Steve Sugino, President & Representative Director
Steve Sugino became Vice President of Amgen Inc. and General Manager of Amgen Astellas BioPharma (Amgen Astellas) in April 2017. As of June 1, 2017, he has been appointed as the President and Representative Director of Amgen Astellas. Prior to this role, he worked over 20 years in the pharmaceutical industry where he held various roles of increasing responsibility in general management, sales and marketing, clinical development, business development and alliance management in both Japan and the US.
Sugino, a fourth generation of Japanese-American, graduated with a degree in Asian Studies from the University of California, Santa Barbara and started his career at the Bank of Tokyo in Japan before moving to Credit Suisse First Boston as an investment banker in both Tokyo and New York. He led Sanofi Japan’s diabetes business. At Eli Lilly, he held a global brand development role for the neuroscience portfolio and other neuroscience molecules, working out of the US headquarters. His last role at Eli Lilly was Vice President of US diabetes commercial. He was most recently Head of Asia Pacific, and President and Representative Director of Japan for Biogen where he was responsible for all aspects of Biogen’s operations across the Asia Pacific region and for the fully integrated Japan affiliate.
Kurt Helge Rimkus, M.D., Ph.D, Head of Research and Development
Dr. Rimkus joined Amgen Astellas BioPharma on April 1, 2016 from Shire Japan KK where he held the position of head of Medical Affairs since 2012. Prior to that he worked at MSD KK and its predecessor companies Schering-Plough K.K. and Nippon Organon K.K.,from 2005 to 2012, always as head of the respective Medical Affairs Departments.
Dr. Rimkus earlier professional background includes leadership roles in Marketing & Sales of Diabetes Blood Glucose monitoring devices and rapid diagnostics at Boehringer Mannheim Toho K.K. and in Clinical Development at Boehringer Mannheim Toho K.K. and Nihon Schering K.K.
Dr. Rimkus earned an M.D. and Ph.D. in pathology from the University of Saarland, Medical School in Germany and he pursued further studies at the Hyogo College of Medicine in Japan. He was trained in Urology at the University of Saarland and at the Hyogo College of Medicine.
Yukiya Suzuki, Head of Sales & Marketing
Mr. Suzuki joined Amgen Astellas BioPharma K.K., on October 1, 2013 as Head of Marketing. Prior to joining Amgen Astellas BioPharma, he was Executive Director of Strategic Planning at Product Marketing for Astellas Pharma Inc.’s Sales & Marketing Division. He began his career at Yamanouchi Pharmaceutical Co., Ltd., - one of the precursor companies that merged to form Astellas in 2005 - in 1988 and was in charge of sales and marketing. He has served in various positions at the company, including Executive Director of Urology at Product Marketing, Sales & Marketing Division. He graduated from Meiji Pharmaceutical University in Tokyo with a master's degree in pharmaceutical sciences, and from Nihon University with a master's degree in business administration.